BCU-DAP2-62448 - In-Patient Alcohol and Drug Misuse Detoxification Services
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)Estimated Value
Up to £900,000
Deadline
Not specified
Published
12 March 2026
Type
services
Overview
Betsi Cadwaladr University Health Board are seeking a 1 month contract for in-patient alcohol and drug misuse detoxification services. The provider is to staff and conduct the service from the Hafan Wen unit at Wrexham Maelor Hospital. Betsi Cadwaladr University Health Board are looking to utilise Direct Award Option 2 under the Health Services (Provider Selection Regime) (Wales) Regulations 2025
AI AnalysisMembers
Requirements, key tasks and tips for reading this tender — included with Tendarix membership.
£4.99/month after a 7-day free trial. Cancel anytime before it ends and you pay nothing.
Award Details
ADFERIAD RECOVERY LIMITED
£900,000
Likely incumbents
Suppliers who won similar work from this buyer in the last 5 years.
- 1
ADFERIAD RECOVERY LIMITED
2 contracts wonlatest 1 Sept 2026£502,974
total awarded
- 2
Kaleidoscopeproject
2 contracts wonlatest 16 Apr 2026£2m
total awarded
- 3
Health Is One Ltd
1 contract wonlatest 1 Sept 2026£333,333
total awarded
- 4
Platfform
1 contract wonlatest 1 Sept 2026£333,333
total awarded
- 5
Adferiad
1 contract wonlatest 1 Sept 2026£1m
total awarded
ADFERIAD RECOVERY LIMITED is the most likely incumbent based on recency and category match. To win, bidders typically need a clearly differentiated proposition or a price advantage.
Before you bid, buyers check
two years of filed accountsyour financial standingturnover vs contract valueyour Companies House recordcash flow for 30-day termscredit scores and ratios
Actions
Start free trialto open noticeCreate an account and start a 7-day free trial to open the buyer’s own notice and tender documents, plus fit scoring and the Bid Writer. Then £4.99/month — cancel anytime.
Open Bid WriterIndependent software, web & cloud studio. We design, build and grow digital products that quietly outlast their category.
How to Apply
Step-by-step submission guide
Submission Portal
Find a Tender
Open the original notice
Click the button below to view the full notice on Find a Tender Service (FTS)
Check the procedure type
The "Procedure" section tells you if it's Open (one stage) or Restricted (SQ then ITT). This changes how you apply
Access the eSourcing portal
FTS notices link to the buyer's eSourcing platform — register there to access documents
Complete the Selection Questionnaire
Higher-value contracts often require an SQ first — this pre-qualifies you before the full bid stage
Submit electronically
Upload your completed response through the eSourcing platform before the closing date and time
FTS contracts are above UK procurement thresholds. Late submissions are strictly rejected — submit at least 24 hours before the deadline to avoid portal issues.
Buyer Profile
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)Key Dates
Published
12 March 2026
Submission deadline
Not specified
Notice type
award
Source
find a tender
Related Tenders
CA18552 - RFQ 2026/40 - nmandd peaceplus "thriving together" - 3.2 minority community support programme - journeys & belonging
Competent consultancy companies are hereby invited to tender to design, develop and deliver a minority community support programme, that will be delivered across the Rowallane and
Supply & delivery of various city & guilds training courses & certification
Invitation to Tender for Supply & Delivery of various City & Guilds Training Courses & Certification. Apply via the in-tend procurement portal: https://supplier.in-tend
Managed IT and cyber security service provider - pre-qualification (stage 1 of 2)
North East Autism Society (NEAS), a North East England charity, is seeking to appoint a Managed Service Provider (MSP) to deliver managed IT and cyber security services across the
Targeted prostate cancer screening programme - MRI reporting service
The Contracting Authority is procuring a targeted prostate cancer screening pathway with a focus on men at increased risk due to an inherited BRCA2 variant utilising the competitiv